Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ACURATE neo2™ Post Market Clinical Follow up Study

NCT04655248 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT04655248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04655248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ACURATE neo2™ Post Market Clinical Follow up Study
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Active, not recruiting
Start date
December 16, 2020
Completion date
December 31, 2026
Enrollment
250 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

aortic diseases, aortic valve calcification, aortic valve stenosis